GLP-1
Compounded GLP-1 receptor agonist therapies (semaglutide, tirzepatide) for weight management.
Semaglutide + Glycine
A GLP-1 receptor agonist, semaglutide is compounded as a sterile injectable solution. It supports blood glucose regulation and is commonly formulated for weight management, working by reducing appetite and slowing gastric emptying. It is typically used alongside a reduced-calorie diet and increased physical activity.
Semaglutide +B6
A GLP-1 receptor agonist, semaglutide is compounded as a sterile injectable solution. It supports blood glucose regulation and is commonly formulated for weight management, working by reducing appetite and slowing gastric emptying. It is typically used alongside a reduced-calorie diet and increased physical activity.
Tirzepatide +B6
Acting on both GIP and GLP-1 receptors, tirzepatide is compounded as a sterile injectable solution. It supports blood glucose regulation and is commonly formulated for weight management, working to help reduce appetite and slow gastric emptying alongside a reduced-calorie diet and increased physical activity.
Tirzepatide +Glycine
Acting on both GIP and GLP-1 receptors, tirzepatide is compounded as a sterile injectable solution. It supports blood glucose regulation and is commonly formulated for weight management, working to help reduce appetite and slow gastric emptying alongside a reduced-calorie diet and increased physical activity.
Tirzepatide +Semaglutide
Acting on both GIP and GLP-1 receptors, tirzepatide is compounded as a sterile injectable solution. It supports blood glucose regulation and is commonly formulated for weight management, working to help reduce appetite and slow gastric emptying alongside a reduced-calorie diet and increased physical activity.